Chengzhi Co., Ltd. (SHE:000990)
China · Delayed Price · Currency is CNY 6.47
-0.22 (-3.29%)
Sep 11, 2026, 3:04 PM CST
Chengzhi Market Cap
Chengzhi has a market cap or net worth of 11.01 billion as of September 11, 2026. Its market cap has increased by 14.95% in one year.
Market Cap
11.01B
Enterprise Value
14.32B
Revenue
11.19B
Ranking
n/a
PE Ratio
57.11
Stock Price
6.47
ChartMarket Cap Chart
Since January 2, 2001, Chengzhi's market cap has increased from 4.51B to 11.01B, an increase of 144.27%. That is a compound annual growth rate of 3.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 11.01B | 14.37% |
| Dec 31, 2025 | 9.62B | 2.19% |
| Dec 31, 2024 | 9.42B | -5.60% |
| Dec 29, 2023 | 9.98B | -6.70% |
| Dec 30, 2022 | 10.69B | -44.37% |
| Dec 31, 2021 | 19.23B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 12.33B |
| Sino Biological,Inc. | 12.12B |
| Inner Mongolia Furui Medical Science | 11.73B |
| Tibet Cheezheng Tibetan Medicine | 11.46B |
| Chengdu Olymvax Biopharmaceuticals | 11.43B |
| Mabwell (Shanghai) Bioscience | 11.43B |
| InventisBio | 11.36B |
| Hualan Biological Vaccine | 11.00B |